2-Imidazolidinone, 1-[2-(1-piperazinyl)ethyl]-(104087-61-8)
- Name: 2-Imidazolidinone, 1-[2-(1-piperazinyl)ethyl]-
- Synonyms:
- Molecular Formula:C9H18N4O
- Molecular Weight:198.268
- CAS Registry Number:104087-61-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.104087-61-8 1-[2-(piperazin-1-yl)ethyl]imidazolidin-2-one
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.104087-61-8 2-Imidazolidinone, 1-[2-(1-piperazinyl)ethyl]-
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)] CAS No.104087-61-8 1-[2-(piperazin-1-yl)ethyl]imidazolidin-2-one;104087-61-8
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 104083-83-2/1H-Indazol-7-ol, 4-(2-aminoethyl)-
- 104083-85-4/Methanesulfonamide, N-[4-(2-aminoethyl)-1H-indazol-7-yl]-
- 104083-86-5/3H-Indazol-3-one, 4-[2-(dipropylamino)ethyl]-1,2-dihydro-7-hydroxy-
- 104083-87-6/3H-Indazol-3-one, 4-(2-aminoethyl)-1,2-dihydro-7-hydroxy-
- 104083-88-7/3H-Indazol-3-one, 5-(2-aminoethyl)-1,2-dihydro-7-hydroxy-
- 104083-90-1/3H-Indazol-3-one, 4-[2-(dipropylamino)ethyl]-1,2-dihydro-7-methoxy-
- 104083-91-2/3H-Indazol-3-one, 5-(2-aminoethyl)-1,2-dihydro-7-methoxy-
- 104083-93-4/Urea, [4-(2-aminoethyl)-2-hydroxyphenyl]-
- 104084-46-0/3-Pyridinecarboxamide, 4-(hydroxyphenylmethyl)-N,N-bis(1-methylethyl)-
- 104084-69-7/9,10-Anthracenedione, 1-(1,4,7,10,13-pentaoxacyclopentadec-2-ylmethoxy)-
- 104084-81-3/Propanoic acid, 3-(benzoylamino)-3-thioxo-, ethyl ester
- 104085-37-2/2H-Oxocin-2-one, 8-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-3,4,7,8-tetrahydro-
- 104085-63-4/Magnesium, chloro-1-propynyl-
- 104085-97-4/1,1'-Biphenyl, 2-(methylsulfonyl)-
- 104086-50-2/2-Butenoic acid, 4-[(2-chlorophenyl)(2-cyanoethyl)amino]-4-oxo-, (Z)-
- 104086-51-3/2-Butenediamide, N-(2-chlorophenyl)-N-(2-cyanoethyl)-N',N'-dimethyl-, (E)-
- 10408-65-8/1H-Benz[e]inden-1-one, 2,3-diphenyl-
- 104086-63-7/Benzeneacetic acid, (1R,3-endo,5S,6S,7R)-6,7-dihydroxy-8-methyl-8-azabicyclo[3.2.1]oct-3 -yl ester, rel-
- 10408-73-8/1H-Inden-1-one, 3-methyl-2-phenyl-
- 104087-61-8/2-Imidazolidinone, 1-[2-(1-piperazinyl)ethyl]-
- 10408-82-9/Naphtho[2,3-c]furan-1(3H)-one, 9-phenyl-3-(phenylmethylene)-
- 104088-69-9/Octadecanoic acid, 2,2,2-trifluoroethyl ester
- 104088-70-2/Spiro[2H-indole-2,3'-[3H]naphth[2,1-b][1,4]oxazine], 1,3-dihydro-1-[(4-methoxyphenyl)methyl]-3,3-dimethyl-
- 104088-71-3/Spiro[2H-indole-2,3'-[3H]naphth[2,1-b][1,4]oxazine], 1,3-dihydro-3,3-dimethyl-1-[(2-methylphenyl)methyl]-
- 104088-72-4/Spiro[2H-indole-2,3'-[3H]naphth[2,1-b][1,4]oxazine], 1,3-dihydro-3,3-dimethyl-1-[(3-methylphenyl)methyl]-
- 104088-73-5/Spiro[2H-indole-2,3'-[3H]naphth[2,1-b][1,4]oxazine], 1-[(3,5-dimethylphenyl)methyl]-1,3-dihydro-3,3-dimethyl-
- 104088-74-6/Spiro[2H-indole-2,3'-[3H]naphth[2,1-b][1,4]oxazine], 1,3-dihydro-3,3-dimethyl-1-[(2,4,6-trimethylphenyl)methyl]-
- 104088-75-7/Spiro[2H-indole-2,3'-[3H]naphth[2,1-b][1,4]oxazine], 1-[(4-chlorophenyl)methyl]-1,3-dihydro-3,3-dimethyl-
- 104088-76-8/Spiro[2H-indole-2,3'-[3H]naphth[2,1-b][1,4]oxazine], 1-[(2-fluorophenyl)methyl]-1,3-dihydro-3,3-dimethyl-
- 104088-78-0/Spiro[2H-indole-2,3'-[3H]naphth[2,1-b][1,4]oxazine], 1-[(4-fluorophenyl)methyl]-1,3-dihydro-3,3-dimethyl-